lumi tirzepatide Tier 1 Company of the Year 2025:
Description
Access oral GLP-1 tablets with clinician oversight, personalized dosing, side-effect support, labs, and coaching to improve nutrition and preserve muscle.
Once weekly tirzepatide is approved in the US and EU for the treatment of type 2 diabetes (T2D) and obesity
People looking to lose weight are urged to work with their doctor and a trusted pharmacy.
Data Sources The PubMed and EMBASE databases were searched up to November, 1st 2023
/PRNewswire/ -- Millions of patients are on GLP-1 medications
Manhattan, KS
